• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC 4.17% 10.0¢

IMMURON LIMITED

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMC 10:56 21 4.2K
10:56 Last post  Cornhulio Comments Created with Sketch.  21  Views Created with Sketch.  4.2K 
IMC 15/03/24 147 38K
15/03/24 Last post  awildana Comments Created with Sketch.  147  Views Created with Sketch.  38K 
IMC 14/03/24 5 1.0K
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
14/03/24 Last post  Ebbcg Comments Created with Sketch.  5  Views Created with Sketch.  1.0K 
IMC 14/03/24 0 158
14/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  158 
IMC 14/03/24 0 167
14/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
IMC 14/03/24 0 222
14/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  222 
IMC 08/03/24 28 7.1K
08/03/24 Last post  dazatoN Comments Created with Sketch.  28  Views Created with Sketch.  7.1K 
IMC
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
07/03/24 27 5.8K
07/03/24 Last post  _THEDON_ Comments Created with Sketch.  27  Views Created with Sketch.  5.8K 

See All Discussions arrow Created with Sketch.

Timeline

Notice under section 708A
14 Mar 10:53
 
Change of Director's Interest Notice (DP)
14 Mar 10:45
 
Application for quotation of securities - IMC
14 Mar 10:40
 
Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
14 Mar 08:25
 
Change in substantial holding
14 Mar 08:20
 
Travelan to progress to Phase 3 Clinical Trials in the US
07 Mar 10:03
 
View More arrow Created with Sketch.
(20min delay)
Last
10.0¢
Change
0.004(4.17%)
Mkt cap ! $22.8M
Open High Low Value Volume
9.8¢ 10.5¢ 9.8¢ $60.01K 602.3K

Buyers (Bids)

No. Vol. Price($)
2 119980 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 73673 5
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
10.0¢
  Change
0.004 ( 4.17 %)
Open High Low Volume
9.6¢ 10.5¢ 9.6¢ 528150
Last updated 15.58pm 19/03/2024 ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.